Segment and Geographic Information

9 Months Ended

Sep. 30, 2012

Segment and Geographic Information

14. Segment and Geographic Information

The Company has one reportable operating segment, the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.

Product revenue by product group is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Orthobiologics	$	9,242,783	$	10,377,222	$	30,262,991	$	28,177,115
Dermal		376,251		947,122		1,033,302		2,335,881
Ophthalmic		1,891,433		4,562,574		8,515,160		8,045,203
Surgical		1,426,273		1,068,522		3,874,405		3,748,277
Veterinary		1,118,700		800,560		2,865,187		1,924,364
	$	14,055,440	$	17,756,000	$	46,551,045	$	44,230,840

Product revenue by geographic location in total and as a percentage of total product revenue, for the three and nine months ended September 30, 2012 and 2011 are as follows (Prior period numbers have been reclassified to conform to the current period presentaion):

	Three Months Ended September 30,
	2012					2011
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	11,911,946		85	%	$	13,233,998		75	%
Europe		1,069,661		7	%		2,512,690		14	%
Other		1,073,833		8	%		2,009,312		11	%
Total	$	14,055,440		100	%	$	17,756,000		100	%

	Nine Months Ended September 30,
	2012					2011
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	38,317,667		82	%	$	33,170,393		75	%
Europe		3,937,427		9	%		6,887,323		16	%
Other		4,295,951		9	%		4,173,124		9	%
Total	$	46,551,045		100	%	$	44,230,840		100	%